Literature DB >> 16897014

High frequency spikes in long period blood cell oscillations.

Caroline Colijn1, A C Fowler, Michael C Mackey.   

Abstract

Several hematological diseases are characterised by oscillations of various blood cell populations. Two of these are a variant of chronic myelogenous leukemia (CML) and cyclical neutropenia (CN). These oscillations typically have long periods ranging from 20 to 60 days, despite the fact that the stem cell cycling time is thought to be of the order of 2-3 days. Clinical data from humans and laboratory data from the grey collie animal model of CN is suggestive of the idea that these long period oscillations may also contain higher frequency spiky oscillations. We show how such oscillations can be understood in the context of slow periodic stem cell oscillations, by analysing a two component differential-delay equation model of stem cell and neutrophil populations.

Entities:  

Mesh:

Year:  2006        PMID: 16897014     DOI: 10.1007/s00285-006-0027-9

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  24 in total

1.  Hematopoietic dynamics in grey collies.

Authors:  C Haurie; R Person; D C Dale; M C Mackey
Journal:  Exp Hematol       Date:  1999-07       Impact factor: 3.084

2.  Oscillations in cyclical neutropenia: new evidence based on mathematical modeling.

Authors:  Samuel Bernard; Jacques Bélair; Michael C Mackey
Journal:  J Theor Biol       Date:  2003-08-07       Impact factor: 2.691

3.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.

Authors:  G T Williams; C A Smith; E Spooncer; T M Dexter; D R Taylor
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

Review 4.  Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

Authors:  C Haurie; D C Dale; M C Mackey
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

5.  [Spontaneous cyclic leukocytosis in a case of chronic myeloid leukemia (author's transl)].

Authors:  J Delobel; P Charbord; P Passa; J Bernard
Journal:  Nouv Rev Fr Hematol       Date:  1973 Mar-Apr

6.  Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia.

Authors:  H Vodopick; E M Rupp; C L Edwards; F A Goswitz; J J Beauchamp
Journal:  N Engl J Med       Date:  1972-02-10       Impact factor: 91.245

7.  Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy.

Authors:  B J Kennedy
Journal:  Blood       Date:  1970-06       Impact factor: 22.113

8.  Marked cyclic leukocytosis-leukopenia in chronic myelogenous leukemia.

Authors:  A R Rodriguez; C L Lutcher
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

9.  Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF.

Authors:  C Haurie; D C Dale; M C Mackey
Journal:  Exp Hematol       Date:  1999-03       Impact factor: 3.084

10.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

View more
  3 in total

1.  Neutropenia dynamics in a case of T-LGL lymphoproliferation illustrate rapid turnover of granulocyte progenitors.

Authors:  C M Wolfrom; V Lévy; J Deschatrette
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

Review 2.  Dynamic hematological disease: a review.

Authors:  Catherine Foley; Michael C Mackey
Journal:  J Math Biol       Date:  2008-03-04       Impact factor: 2.259

3.  Cell lineage branching as a strategy for proliferative control.

Authors:  Gentian Buzi; Arthur D Lander; Mustafa Khammash
Journal:  BMC Biol       Date:  2015-02-19       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.